Literature DB >> 24370646

Relationship between serum leptin level and disease activity in patients with systemic sclerosis.

Mahmut Budulgan1, Banu Dilek, Şevin Buluttekin Dağ, Ibrahim Batmaz, İsmail Yıldız, Mustafa Akif Sarıyıldız, Remzi Çevik, Kemal Nas.   

Abstract

To determine the relationship between serum leptin levels and disease activity in systemic sclerosis (SSc). A total of 60 subjects (30 controls and 30 patients) were included. The inflammatory markers and leptin levels were evaluated and body mass index (BMI) was measured for both groups. The assessment of the skin involvement was performed based on the modified Rodnan skin score (mRSS). Disease activity was evaluated according to the Valentini scleroderma disease activity index. There was a significant difference between the patient and control groups in terms of BMI (p < 0.05); however there was no difference with regards to age and gender (p > 0.05). Valentini scores and mRSS were determined to be significantly higher in active patients (n = 14) than in inactive patients (n = 16) (p < 0.05). No significant difference was determined between groups in terms of leptin levels (p > 0.05). However, leptin levels were significantly lower in active patients than in inactive patients (p < 0.05). We found a significant positive correlation between serum leptin and BMI (p < 0.05), and leptin and serum C3 levels (p < 0.05); no relationship was detected between leptin and other parameters. Leptin can be used as an activity marker in SSc. Further studies, including larger series, should be carried out to clarify this relationship.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24370646     DOI: 10.1007/s10067-013-2459-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  26 in total

1.  Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis.

Authors:  H J Anders; M Rihl; A Heufelder; O Loch; M Schattenkirchner
Journal:  Metabolism       Date:  1999-06       Impact factor: 8.694

2.  A decreased serum leptin level in patients with systemic sclerosis.

Authors:  A Kotulska; E J Kucharz; L Brzezińska-Wcisło; U Wadas
Journal:  Clin Rheumatol       Date:  2001       Impact factor: 2.980

3.  Serum leptin, resistin and TNF-α levels in patients with systemic sclerosis: the role of adipokines in scleroderma.

Authors:  Yavuz Pehlivan; Ahmet Mesut Onat; Nurdan Ceylan; Ibrahim Halil Turkbeyler; Hakan Buyukhatipoglu; Gazi Comez; Taner Babacan; Mehmet Tarakcioglu
Journal:  Int J Rheum Dis       Date:  2012-06-29       Impact factor: 2.454

4.  A disease severity scale for systemic sclerosis: development and testing.

Authors:  T A Medsger; A J Silman; V D Steen; C M Black; A Akesson; P A Bacon; C A Harris; S Jablonska; M I Jayson; S A Jimenez; T Krieg; E C Leroy; P J Maddison; M L Russell; R K Schachter; F A Wollheim; H Zacharaie
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

5.  Serum leptin levels in rheumatoid arthritis and relationship with disease activity.

Authors:  Rezzan Gunaydin; Taciser Kaya; Aysenur Atay; Nese Olmez; Aysel Hur; Mehmet Koseoglu
Journal:  South Med J       Date:  2006-10       Impact factor: 0.954

6.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

Review 7.  Unraveling the multiple roles of leptin in inflammation and autoimmunity.

Authors:  Antonio La Cava; Carlo Alviggi; Giuseppe Matarese
Journal:  J Mol Med (Berl)       Date:  2003-10-10       Impact factor: 4.599

8.  Independent association between plasma leptin and C-reactive protein in healthy humans.

Authors:  Abu S M Shamsuzzaman; Mikolaj Winnicki; Robert Wolk; Anna Svatikova; Bradley G Phillips; Diane E Davison; Peter B Berger; Virend K Somers
Journal:  Circulation       Date:  2004-04-26       Impact factor: 29.690

9.  Serum leptin in systemic lupus erythematosus.

Authors:  M Wisłowska; M Rok; K Stepień; A Kuklo-Kowalska
Journal:  Rheumatol Int       Date:  2008-01-15       Impact factor: 2.631

Review 10.  Leptin in the regulation of immunity, inflammation, and hematopoiesis.

Authors:  G Fantuzzi; R Faggioni
Journal:  J Leukoc Biol       Date:  2000-10       Impact factor: 4.962

View more
  10 in total

1.  Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis.

Authors:  Y H Lee; G G Song
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

2.  Clinical associations of serum leptin and leptin/adiponectin ratio in systemic sclerosis.

Authors:  Małgorzata Michalska-Jakubus; Karolina Sawicka; Emilia Potembska; Małgorzata Kowal; Dorota Krasowska
Journal:  Postepy Dermatol Alergol       Date:  2018-05-16       Impact factor: 1.837

Review 3.  The Important Role of Leptin in Modulating the Risk of Dermatological Diseases.

Authors:  Xin Su; Ye Cheng; Dong Chang
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

4.  The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic Sclerosis.

Authors:  Gianluca Bagnato; Erika Pigatto; Alessandra Bitto; Gabriele Pizzino; Natasha Irrera; Giuseppina Abignano; Antonino Ferrera; Davide Sciortino; Michelle Wilson; Francesco Squadrito; Maya H Buch; Paul Emery; Elisabetta Zanatta; Sebastiano Gangemi; Antonino Saitta; Franco Cozzi; William Neal Roberts; Francesco Del Galdo
Journal:  Front Med (Lausanne)       Date:  2021-03-17

Review 5.  Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis.

Authors:  Irene Rosa; Eloisa Romano; Bianca Saveria Fioretto; Marco Matucci-Cerinic; Mirko Manetti
Journal:  World J Stem Cells       Date:  2021-01-26       Impact factor: 5.326

6.  Circulating CTRP9 Is Associated With Severity of Systemic Sclerosis-Associated Interstitial Lung Disease.

Authors:  Monica M Yang; Lauren C Balmert; Roberta Goncalves Marangoni; Mary Carns; Monique Hinchcliff; Benjamin D Korman; John Varga
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-07-12       Impact factor: 5.178

7.  Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis.

Authors:  Anna Stochmal; Joanna Czuwara; Michał Zaremba; Lidia Rudnicka
Journal:  Arch Dermatol Res       Date:  2019-10-30       Impact factor: 3.017

8.  The relationship between serum leptin level and disease activity and inflammatory markers in fibromyalgia patients.

Authors:  Safinaz Ataoglu; Handan Ankarali; Rumeysa Samanci; Mustafa Ozsahin; Ozlem Admis
Journal:  North Clin Istanb       Date:  2018-04-16

Review 9.  The role of leptin in selected skin diseases.

Authors:  Klaudia Dopytalska; Agnieszka Baranowska-Bik; Marek Roszkiewicz; Wojciech Bik; Irena Walecka
Journal:  Lipids Health Dis       Date:  2020-10-02       Impact factor: 3.876

10.  Body mass index and adipokines/cytokines dysregulation in systemic sclerosis.

Authors:  Florenzo Iannone; Emanuela Praino; Cinzia Rotondo; Dorotea Natuzzi; Rita Bizzoca; Nunzia Lacarpia; Marco Fornaro; Fabio Cacciapaglia
Journal:  Clin Exp Immunol       Date:  2021-08-16       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.